Wednesday, 09 September 2026 10:30 AM
Class Action
NEW YORK CITY, NY / ACCESS Newswire / September 9, 2026 / Levi & Korsinsky notifies investors that it has commenced an investigation into Novartis AG ("Novartis AG") (NYSE:NVS) concerning potential violations of the federal securities laws.
Novartis AG shares fell sharply on September 8, 2026, after the company announced two back-to-back Phase 3 trial failures. First, on Friday, September 4, 2026, Novartis announced pelacarsen failed to meet its primary endpoint in the Phase 3 HORIZON pioneering cardiovascular outcomes study. The drug trial was unsuccessful in demonstrating statistically significant reductions in cardiovascular events.
Following this, on Monday, September 8, 2026, Novartis announced its experimental drug del-desiran failed to meet its primary endpoint in the Phase 3 HARBOR trial for myotonic dystrophy type 1. The drug did not show a statistically significant improvement compared to a placebo in video hand-opening time.
If you suffered a loss on your Novartis AG securities and would like to explore a potential recovery under the federal securities laws, Learn More About the Investigation or contact Joseph E. Levi, Esq. via email at [email protected] or call (212)363-7500 to speak to our team of experienced shareholder advocates.
WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212)363-7500
Fax: (212)363-7171
SOURCE: Levi & Korsinsky, LLP